MPZL1 Polyclonal antibody

MPZL1 Polyclonal Antibody for WB, ELISA
Cat No. 29784-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse, rat

应用

WB, ELISA

PZR1b, PZR, Protein zero-related, Protein zero related, Myelin protein zero-like protein 1

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inA549 cells, HEK-293 cells, human placenta tissue, mouse kidney tissue, mouse liver tissue, rat kidney tissue, rat liver tissue

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:8000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

29784-1-AP targets MPZL1 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human, mouse, rat
免疫原 MPZL1 fusion protein Ag31532 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 myelin protein zero-like 1
别名 PZR1b, PZR, Protein zero-related, Protein zero related, Myelin protein zero-like protein 1
计算分子量29 kDa
观测分子量32 kDa
GenBank蛋白编号BC007881
基因名称 MPZL1
Gene ID (NCBI) 9019
RRIDAB_3669695
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDO95297
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Myelin protein zero-like 1 (MPZL1, also known as PZR) is a transmembrane glycoprotein that promotes the migration of hepatocellular carcinoma cells and is involved in extracellular matrix-induced signal transduction (PMID: 16702974; 8912526). Phosphorylated MPZL1 was linked to the regulation of cell adhesion and migration (PMID: 24296779; 18378677; 12410637). The expression levels of MPZL1 were also associated with malignant features of ovarian cancer (PMID: 31233194).

实验方案

Product Specific Protocols
WB protocol for MPZL1 antibody 29784-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...